|
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 17 studies with search of: | "HYDROXYUREA"[TREATMENT] AND HIV [CONDITION] |
|
Hide studies that are not seeking new volunteers.
|
|
| 1 | Terminated | Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Indinavir sulfate; Drug: Ritonavir; Drug: Hydroxyurea; Drug: Stavudine; Drug: Didanosine | |||||
| 2 | Completed | A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Hydroxyurea; Drug: Nelfinavir mesylate; Drug: Stavudine; Drug: Didanosine | |||||
| 3 | Terminated | A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Indinavir sulfate; Drug: Lamivudine/Zidovudine; Drug: Hydroxyurea; Drug: Lamivudine; Drug: Stavudine; Drug: Zidovudine; Drug: Didanosine | |||||
| 4 | Completed | Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Biological: Tetanus Toxoid Vaccine; Drug: Hydroxyurea; Drug: Didanosine | |||||
| 5 | Completed | Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Hydroxyurea; Drug: Stavudine; Drug: Didanosine | |||||
| 6 | Completed | A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Hydroxyurea; Drug: Nelfinavir mesylate; Drug: Stavudine; Drug: Didanosine | |||||
| 7 | Completed | A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Hydroxyurea; Drug: Efavirenz; Drug: Stavudine; Drug: Didanosine | |||||
| 8 | Completed | Safety and Effectiveness of a Combination Anti-HIV Drug Treatment | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Hydroxyurea; Drug: Abacavir sulfate; Drug: Efavirenz; Drug: Didanosine | |||||
| 9 | Completed | A Study of MKC-442 in Combination With Other Anti-HIV Drugs | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Emivirine; Drug: Hydroxyurea; Drug: Stavudine; Drug: Didanosine | |||||
| 10 | Completed | The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Hydroxyurea; Drug: Didanosine | |||||
| 11 | Completed | A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Hydroxyurea; Drug: Efavirenz; Drug: Stavudine; Drug: Didanosine | |||||
| 12 | Terminated | The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Emivirine; Drug: Hydroxyurea; Drug: Delavirdine mesylate; Drug: Stavudine; Drug: Didanosine | |||||
| 13 | Terminated | The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Emivirine; Drug: Hydroxyurea; Drug: Nevirapine; Drug: Stavudine; Drug: Didanosine | |||||
| 14 | Completed | Combination Drug Treatment of Pediatric HIV Infection | ||||
| Condition: | HIV Infection | |||||
| Intervention: | Drug: Hydroxyurea | |||||
| 15 | Completed | A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Indinavir sulfate; Drug: Lamivudine/Zidovudine; Drug: Ritonavir; Drug: Hydroxyurea; Drug: Abacavir sulfate; Drug: Amprenavir; Drug: Nelfinavir mesylate; Drug: Efavirenz; Drug: Lamivudine; Drug: Stavudine; Drug: Zidovudine; Drug: Didanosine | |||||
| 16 | Completed | A Study to Probe the Safety and Durability of Tenofovir and a Cell Cycle Agent to Maintain Viral Suppression | ||||
| Conditions: | HIV Infections; AIDS | |||||
| Interventions: | Drug: Tenofovir; Drug: Hydroxyurea | |||||
| 17 | Active, not recruiting | Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs | ||||
| Conditions: | HIV Infections; Peripheral Nervous System Disease | |||||
| Intervention: | ||||||